ARCHIVES

Cancer Education Applications Suspended Pending Restructuring

This article is from The Cancer Letter archive.

Vol. 12 No. 12 | March 21, 1986

Download PDF Visit The Full Archive

Related Articles

Collins, Lander, Botstein Win Albany Prize.

March 12, 2010

NIH Sets Tuition Cost Policy For NRSA Grants

February 9, 1996

NIH Cool On OIG, But the Awardees Love it, DeVita Says

October 17, 1986

Varmus Appoints Group On Intellectual Property

May 8, 1998

Protocols Approved During the Month of June 2002

July 26, 2002

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004